Here, we have shown that SNCA+/− and SNCA−/− mDA neurons can be generated by a straight‐forward genome engineering method via hESCs or iPSCs, and they present a significant opportunity to produce next‐generation cell products that exhibit resistance to Parkinson's pathology. Here, SNCA is linked to Parkinson disease.